Actively Recruiting
A Randomized Controlled, Open Clinical Trial of a Web-based Platform for Multifactorial Intervention in Cancer Pain Management
Led by West China Hospital · Updated on 2026-04-30
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Cancer pain is a common and challenging symptom in patients with malignant tumors, especially in rural areas where medical resources and understanding of cancer pain are limited. This trial aims to improve cancer pain management by integrating it into chronic disease care and enhancing healthcare quality for rural participants using a new digital tool. The study is a randomized controlled, open clinical trial sponsored by West China Hospital, focusing on patients with tumor-related pain requiring morphine-based treatment. Participants will be randomly assigned to either the conventional treatment group, which follows standard cancer pain management without patient feedback or alerts, or an experimental group using a patient self-reporting applet. This applet includes questionnaires on cancer pain and quality of life, allowing patients to report symptoms and changes promptly to primary care doctors. The app monitors patient data in real time and alerts doctors when pain reaches moderate-to-severe levels, side effects occur, or medication adherence is poor, enabling timely intervention and coordination with higher-level hospitals. During the study, participants will use the applet for three months. The app will be used once weekly to assess average pain levels, and twice weekly to evaluate mood, physical state, family burden, and quality of life through validated questionnaires. Researchers will monitor these outcomes to assess the app's impact on cancer pain management. The study includes safety monitoring and follow-up, aiming to improve patient care and health outcomes throughout the participation period.
CONDITIONS
Brief Title
A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with tumors confirmed by pathological findings
- Have tumor-related pain that is moderate or higher requiring morphine-based pain medication
- Have a life expectancy of more than 6 months
- Understand and sign consent, or have a caregiver who understands the study if the patient cannot
You will not qualify if you...
- Presence of other chronic non-cancer pain or unresolved pain-related conditions
- Moderately severe cognitive impairment
- Diagnosis of schizophrenia or other psychiatric illness
- Neither the patient nor caregiver can understand how to use the cancer pain management applet
- Being pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants use a patient self-reporting applet to report symptoms and manage cancer pain with support from primary care doctors.
Weekly app use for symptom reporting and twice weekly app use for quality of life and mood assessments
Trial Site Locations
Total: 1 location
1
West China Hospital, Sichuan Universit
Chengdu, Sichuan, China, 610041
Actively Recruiting
Research Team
X
Xingchen Peng
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here